Gefriderm cutaneous spray solution for dogs
Gefriderm cutaneous spray solution for dogs
Authorised
- Marbofloxacin
- Ketoconazole
- Prednisolone
Product identification
Medicine name:
Gefriderm cutaneous spray solution for dogs
Gefriderm, nahasprei, lahus koertele
Active substance:
- Marbofloxacin
- Ketoconazole
- Prednisolone
Target species:
-
Dog
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Marbofloxacin1.03/milligram(s)1.00millilitre(s)
-
Ketoconazole2.04/milligram(s)1.00millilitre(s)
-
Prednisolone0.93/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Cutaneous spray, solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD07CA03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- Child resistant polyethylene container with 1 bottle of 30 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Alphavet Zrt.
Marketing authorisation date:
Manufacturing sites for batch release:
- Alpha-Vet Kft.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 2263
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0371/001
Concerned member states:
-
Estonia
-
Germany
-
Ireland
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 9/04/2025
Combined File of all Documents
English (PDF)
Download Published on: 24/07/2025
eu-PUAR-gefriderm-cutaneous-spray-solution-for-dogs-en.pdf
English (PDF)
Download Published on: 12/04/2023